Before you begin your Thanksgiving prep, we recap last week's Clinical Trial Diversity Summit, how the "faceless middleman" is raising your healthcare costs, and promising news from USDA. (890 words, ...

Dr. Matthew Pearson litigates patent cases about pharmaceuticals, chemistry and biology, with a particular focus on biologics and antibody technology. In his work as a scientist, he focused on the ...

Thank you for subscribing to receive emails and communications from the Biotechnology Innovation Organization. Learn more about ways to get involved with BIO.

OncoSynergy is a clinical stage immuno-oncology therapeutics company pioneering a breakthrough approach to significantly improving outcomes for patients suffering from the worst cancers. Our ...

Improving clinical trial diversity is a shared goal with, perhaps, different motivations for different stakeholders, including but not limited to: ensuring safety and efficacy of medical products in ...

Teon Therapeutics is a private biopharma start-up developing a portfolio of small molecules that modulate metabolic signaling pathways in the tumor microenvironment. Teon's lead program is an ...

Thank you for downloading the BIO Membership Brochure! You can access the brochure below, and we will also send you a copy via email to keep for your records and pass along to your colleagues. If you ...

SEngine Precision Medicine Inc. is a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived organoids grown ex-vivo utilizing patient ...

Vaccination is proven to be an effective tool in fighting many pathogens. Driven by the market need in the development of therapecutic vaccines, adjuvants are a necessary component of modern vaccines ...

Javeed Froozan’s corporate development experience spans over 25 years in early stage, growth, and large biopharma and health tech firms. This includes acquiring companies, products and technologies in ...

Aruna Bio, Inc. is a privately funded biotechnology company focused on the development of neural exosomes for the treatment of neurodegenerative diseases. The company utilizes it's proprietary neural ...

KisoJi is a next-generation antibody company developing multi-specific antibodies to improve outcomes in oncology. Using next generation sequencing, machine learning and transgenic technologies, ...